Poloxipan is a novel, potent and pan-PLK inhibitor with IC50 of 3.2 uM for Plk1, 1.7 uM for Plk2; and 3 uM for Plk3. Poloxipan showed minor inhibition over FHA dommain of Chk2, S2 domian of STAT1, STAT5b, Lck, etc.

纯度：≥98%

CAS：1239513-63-3